Document is current
Any future updates will be listed below
-
Authors
Hattori, Takaaki
Mitani, Naoko
Numasawa, Yoshiyuki
Azuma, Reo
Orimo, Satoshi
- License Information
-
More Information
Article History
Received: 6 August 2022
Revised: 23 April 2023
Accepted: 22 May 2023
First Online: 30 May 2023
Declarations
:
: This study was approved by the Institutional Review Board of Kanto Central Hospital (25–4-003), Japan.
: The study was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments.
: All the authors have reviewed the manuscript and agreed for publication. Since this was a retrospective observational cohort study and extracted data were de-identified, written informed consent was waived.
: T.H. has received speaker’s honoraria from (1) Daiichi Sankyo Company, Limited; (2) Sumitomo Dainippon Pharma Co., Ltd.; (3) Integra Japan Co., Ltd; and (4) Kyowa Kirin Co., Ltd.N.M. declares no conflict of interest associated with this manuscript.Y.N. declares no conflict of interest associated with this manuscript.R.A. declares no conflict of interest associated with this manuscript.S.O. received speaker’s honoraria from Eizai Co., Ltd. and Ono pharmaceutical Co., Ltd.
